Follow us on:
Breaking News
June 22, 2026
Breaking News
Breaking News
Adare_Webinar_07-22-26_650x90

Lonza, InduPro Enter Licensing Agreement for Next-Gen ADCs

 
Lonza, InduPro Enter Licensing Agreement for Next-Gen ADCs

InduPro to license Lonza’s linker payload technologies and bioconjugation platforms to help advance its ADC therapeutics.
Read More >>

Headlines

Breaking News
Collaborations & Alliances

SK Pharmteco Partners with OTXL to Tackle Rare Diseases

SK pharmteco will serve as a preferred technical partner, providing critical technical capabilities to accelerate OTXL's pipeline toward clinical and commercial milestones.

SPONSOR

Reducing Risk and Quality Cost in Supplier Qualification

In this Contract Pharma webinar on July 16, learn proven strategies to streamline supplier audits, reduce quality spend, and keep your supply chain compliant. Registration is open!

Breaking News

AdvanCell Establishes U.S. Global HQ and Manufacturing Facility in Greater Boston  

New 128,000-sq.-ft. facility in Andover will support the development and commercialization of ADVC001 and its pipeline of Lead-212 targeted alpha therapies.

Breaking News
Collaborations & Alliances

Neurizon, Elanco Ink Long-Term Supply Agreement for Human Health Monepantel

This supplies Neurizon with the API for its lead asset, a potential therapy for ALS.

SPONSOR

Flexibility in Drug Development: From Tactical Response to Strategic Discipline

How strategic flexibility enables continuity, scalability, and reliable execution in modern drug development.

SPONSOR

[VideoBite] Eliminating Complexity for Pharma Teams

Jai Murthy of Actylis shares insight on overcoming supply chain fragility, buffer prep solutions, and approaches to customization.

Featured Resources

Solution Content Center SPOTLIGHT

Thermo Fisher Scientific Pharma Services

Thermo Fisher Scientific serves the pharmaceutical, biotech, and life sciences industries as a strategic contract development and manufacturing organization (CDMO) and clinical services partner. Thermo Fisher’s end-to-end, integrated CDMO capabilities help companies on their drug development and manufacturing journeys. From research and development to regulatory landscape support, supply chain management, and everywhere in between, the company’s services and solutions support the entire life cycle of drug substances and drug products, from preclinical research to commercial manufacturing. Thermo Fisher knows your challenges and has developed solutions you can trust to help bring your treatment to market faster.

 

Solution Center SPOTLIGHT

LOTTE BIOLOGICS

LOTTE Biologics is a contract development & manufacturing organization delivering integrated biologics & bioconjugate services across the full product lifecycle. Our capabilities encompass phase-appropriate DS manufacturing for mammalian-cell-based biologics, including mAbs, fusion proteins, multispecifics, & integrated ADC manufacturing.